Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Galassi, Alfredo Ruggero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.670
AS - Asia 4.032
EU - Europa 3.815
SA - Sud America 979
Continente sconosciuto - Info sul continente non disponibili 941
AF - Africa 102
OC - Oceania 17
Totale 15.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.435
SG - Singapore 1.521
RU - Federazione Russa 1.347
IT - Italia 1.073
BR - Brasile 771
CN - Cina 739
VN - Vietnam 532
HK - Hong Kong 427
PL - Polonia 315
BD - Bangladesh 244
DE - Germania 229
FR - Francia 208
GB - Regno Unito 137
JP - Giappone 135
FI - Finlandia 134
CA - Canada 109
IN - India 86
AR - Argentina 84
NL - Olanda 67
IQ - Iraq 53
IE - Irlanda 48
AT - Austria 46
TR - Turchia 44
MX - Messico 43
EC - Ecuador 40
SE - Svezia 39
RO - Romania 38
ID - Indonesia 35
PK - Pakistan 31
ZA - Sudafrica 31
ES - Italia 27
UA - Ucraina 24
UZ - Uzbekistan 24
KR - Corea 20
CL - Cile 17
MA - Marocco 17
VE - Venezuela 17
JM - Giamaica 16
CO - Colombia 15
BE - Belgio 14
MY - Malesia 14
EG - Egitto 13
PH - Filippine 13
CR - Costa Rica 12
PY - Paraguay 12
SA - Arabia Saudita 11
TW - Taiwan 11
AL - Albania 10
AU - Australia 10
UY - Uruguay 10
AZ - Azerbaigian 9
BG - Bulgaria 9
CU - Cuba 8
IR - Iran 8
KE - Kenya 8
KZ - Kazakistan 8
NP - Nepal 8
PE - Perù 8
TH - Thailandia 8
BY - Bielorussia 7
CH - Svizzera 7
DZ - Algeria 7
GR - Grecia 7
HN - Honduras 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
TN - Tunisia 6
AO - Angola 5
BO - Bolivia 5
IL - Israele 5
JO - Giordania 5
LB - Libano 5
SV - El Salvador 5
BH - Bahrain 4
KG - Kirghizistan 4
LT - Lituania 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BB - Barbados 3
LC - Santa Lucia 3
QA - Qatar 3
BW - Botswana 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
LV - Lettonia 2
NG - Nigeria 2
RS - Serbia 2
SY - Repubblica araba siriana 2
YE - Yemen 2
AI - Anguilla 1
Totale 14.592
Salva come PNG Salva come JPEG
Città #
Singapore 987
Ashburn 779
San Jose 638
Hong Kong 394
Chandler 351
Zgierz 289
Moscow 217
Fairfield 190
Ho Chi Minh City 178
Council Bluffs 168
Los Angeles 166
Dallas 164
New York 138
Beijing 135
Palermo 130
Lauterbourg 124
Hanoi 121
Tokyo 112
Hefei 109
Milan 107
Rome 107
Santa Clara 105
Houston 94
Helsinki 93
Seattle 83
Woodbridge 83
Chicago 78
Buffalo 75
Medford 74
São Paulo 71
Wilmington 66
Des Moines 60
Altamura 55
Nuremberg 55
Ann Arbor 53
Cambridge 52
Frankfurt am Main 50
Lawrence 47
Princeton 47
Dublin 46
Toronto 46
Boardman 41
London 41
The Dalles 40
Lappeenranta 36
Da Nang 34
Naples 34
Orem 33
San Diego 31
Atlanta 28
Columbus 27
Central 25
Denver 25
Ludwigshafen am Rhein 24
Munich 24
Vienna 24
Salt Lake City 23
San Francisco 23
Venice 23
Bari 22
Haiphong 22
Montreal 21
Shanghai 21
Stockholm 21
Belo Horizonte 19
Redondo Beach 19
Rio de Janeiro 19
Bologna 18
Brooklyn 18
Tashkent 17
Warsaw 17
Amsterdam 16
Johannesburg 16
Recife 16
Baghdad 14
Chennai 14
Manchester 14
Mumbai 14
Paris 14
Phoenix 14
Tampa 14
Brussels 13
Elk Grove Village 13
Florence 13
Guayaquil 13
Buenos Aires 12
Curitiba 12
Guangzhou 12
Istanbul 12
Mexico City 12
Quito 12
Boston 11
Hải Dương 11
Kingston 11
Catania 10
Dhaka 10
Biên Hòa 9
Cagliari 9
Charlotte 9
Erbil 9
Totale 8.066
Salva come PNG Salva come JPEG
Nome #
Evaluation and management of patients with coronary chronic total occlusions considered for revascularisation. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC, and the ESC Working Group on Cardiovascular Surgery 291
ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes. 277
Management strategies in patients affected by chronic total occlusions: Results from the Italian Registry of Chronic Total Occlusions 225
BIOMARKERS OF CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH MICROVASCULAR ANGINA: A NARRATIVE REVIEW 213
A possible easy way to predict response to cardiac resynchronization therapy: The role of QRS Index 204
Temporal trends in chronic total occlusion interventions in Europe: 17626 procedures from the European Registry of Chronic total occlusion 200
Giant unruptured circumflex coronary artery aneurysms presenting as acute coronary syndrome 189
Appropriateness of percutaneous revascularization of coronary chronic total occlusions: An overview 185
Assessment of cancer therapy-related cardiac dysfunction in breast cancer women using a new speckle tracking echocardiography index: The GAVS 178
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice 173
Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia 170
Cardiovascular health in Asian immigrants to Italy: risk factors, pathogenesis and pharmacological treatment 168
Acute inferior myocardial infarction due to a large thrombus in the Left Coronary Sinus of Valsalva 168
Exploring the role of Glial Fibrillary Acid Protein (GFAP) in Acute coronary syndrome 166
Subclinical Atrial Fibrillation on Prolonged ECG Holter Monitoring: Results from the Multicenter Real-World SAFARI (Silent Atrial Fibrillation ANCE-Sicily Research Initiative) Study 158
Outcome of extracorporeal membrane oxygenation support for high-risk percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome 157
Electrocardiographic abnormalities, preclinical carotid atherosclerosis and cardiovascular risk in an apparently healthy real-world population Data from the "no Stroke, No Infarction" project of the Rotary International - District 2110 (Sicily and Malta) 155
Atrial fibrillation and cognitive disorders: An overview on possible correlation 154
Effectiveness and Safety of Oral Anticoagulants in Cardiac Amyloidosis: Lights and Shadows 150
Coronary microvascular dysfunction 146
Myocardial infarction with non-obstructive coronary arteries (MINOCA): Intracoronary imaging-based diagnosis and management 145
Ischemia in patients with no obstructive coronary artery disease: Classification, diagnosis and treatment of coronary microvascular dysfunction 144
Left Ventricular Deformation and Myocardial Work Parameters in Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran: A Single-Center Study 143
EVALUATION OF REMNANT CHOLESTEROL LEVELS AND MONOCYTE-TO-HDL-CHOLESTEROL RATIO IN SOUTH ASIAN PATIENTS WITH ACUTE CORONARY SYNDROME 142
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions 141
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 139
Coronary Arteries Aneurysms: A Case-Based Literature Review 136
Medical therapy or revascularization for patients with chronic total occlusion? A dilemma almost solved 135
Role of Lipoprotein Ratios and Remnant Cholesterol in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) 134
Channel Tracking Guidewire and Technique for Retrograde Approach 131
Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions. 130
The impact of coronavirus disease 2019 on acute coronary syndrome: Differences between epidemic waves 130
Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction 129
Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction 128
Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies cto-arc consensus recommendations 127
When, why, and how to perform wire-based antegrade dissection and reentry technique 127
Longitudinal Strain Analysis and Correlation with TIMI Frame Count in Patients with Ischemia with No Obstructive Coronary Artery (INOCA) and Microvascular Angina (MVA) 126
Dual guidewire balloon antegrade fenestration and re‐entrytechnique for coronary chronic total occlusions percutaneouscoronary interventions 125
Impact of Metabolic Syndrome on Coronary Microvascular Dysfunction: A Single Center Experience 125
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question 124
Correlation between longitudinal strain analysis and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction 124
Percutaneous Coronary Revascularization for Chronic Total Occlusions A Novel Predictive Score of Technical Failure Using Advanced Technologies 123
Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper 123
Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices 122
Ischemia with no obstructive coronary artery disease: microvascular angina and vasospastic angina 122
Management of a patient with multiple device replacements and extractions: When the leadless pacemaker is a viable solution 122
The added value of the HFA/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer 120
Coronary embolism in a young patient with nonbacterial thrombotic endocarditis related to antiphospholipid syndrome 120
Coronary Artery Disease in South Asian Patients: Cardiovascular Risk Factors, Pathogenesis and Treatments 120
Utility of Intravascular Ultrasound in Percutaneous Revascularization of Chronic Total Occlusions 119
Retrograde recanalization of chronic total occlusions in Europe: Procedural, in-hospital, and long-term outcomes from the multicenter ERCTO registry 118
Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club 118
Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! 118
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document 117
The IMPACTOR-CTO Trial 116
Myocardical infarction with non-obstructive coronary arteries (MINOCA): Phatogenesis, diagnosis and treatment 116
Right ventricle involvement in patients with breast cancer treated with chemotherapy 115
Management of Coronary Artery Perforation 115
Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction 114
Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry 114
Coronary Revascularization in Patients with Hemophilia and Acute Coronary Syndrome: Case Report and Brief Literature Review 114
LEFT MAIN CORONARY BIFURCATION TREATMENT WITH IMPELLA SUPPORT IN COMPLEX AND HIGH RISK PATIENT (CHIP) 114
Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management 113
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review 113
Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography 112
Update in the Percutaneous Management of Coronary Chronic Total Occlusions 112
Outcomes With Retrograde Versus Antegrade Chronic Total Occlusion Revascularization 109
Dysfunctional High-Density Lipoprotein Cholesterol and Coronary Artery Disease: A Narrative Review 107
Age and sex differences in the efficacy of early invasive strategy for non-ST-elevation acute coronary syndrome: A comparative analysis in stable patients. 107
Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention 105
Dual lumen microcatheters for recanalisation of chronic total occlusions: A EuroCTO Club expert panel report 104
Excimer laser atherectomy in an uncrossable long chronic total occlusion through the subintimal space 101
Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score 100
Successful use of impella CP through femoral access in a patient with bilateral iliac and aortic endoprosthesis in the setting of cardiogenic shock 100
Screening and Management of Coronary Artery Disease in Kidney Transplant Candidates 97
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: The DERIVATION score 96
Higher Incidence of Cancer Therapy-Related Cardiac Dysfunction in the COVID-19 Era: A Single Cardio-Oncology Center Experience 95
Therapy of ATTR Cardiac Amyloidosis: Current Indications 95
Optimal Timing of Angiography-Guided Complete Revascularization of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 93
Shockwave intravascular lithoplasty for the treatment of calcified carotid artery stenosis: A very early single-center experience 93
Gastrointestinal Bleeding During Long-Term Left Ventricular Assist Device Support: External Validation of UTAH Bleeding Risk Score 92
Apical thrombus in a patient with takotsubo cardiomyopathy 92
Cancer survivors and cardiovascular diseases: from preventive strategies to treatment 90
A novel 3-D reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 90
Outcomes of chronic total occlusion percutaneous coronary intervention from the RAIAN (RAjaie - Iran) registry 89
Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization 89
The ANOCA/INOCA Dilemma Considering the 2024 ESC Guidelines on Chronic Coronary Syndromes 88
Cholesterol-Lowering Strategies for Cardiovascular Disease Prevention: The Importance of Intensive Treatment and the Simplification of Medical Therapy 88
Stent-frame decoupling following self-expandable transcatheter aortic valve replacement. 86
INCIDENTAL FINDING OF INTERRUPTED AORTIC ARCH IN AN ADULT PATIENT UNDERGOING URGENT PERCUTANEOUS CORONARY INTERVENTION 86
Differences in patients and lesion and procedure characteristics depending on the age of the coronary chronic total occlusion 86
Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis 85
Atrial Fibrillation Catheter Ablation in Patients With Hypertrophic Cardiomyopathy: A Systematic Review and Meta-analysis 85
CTO and Bifurcation Lesions: An Expert Consensus From the European Bifurcation Club and EuroCTO Club. 83
Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Predictors of Procedural Success From the ERCTO Registry 83
Risk Burden of Coronary Perforation in Chronic Total Occlusion Recanalization: Latin American CTO Registry Analysis 82
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO). 81
Reclassification of CTO Crossing Strategies in the ERCTO Registry According to the CTO-ARC Consensus Recommendations 81
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents 81
Optimization of Long Superficial Femoral Artery Percutaneous Transluminal Angioplasty by Intraoperative Doppler Ultrasound 80
Totale 12.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022574 0 41 16 26 15 33 12 26 56 192 23 134
2022/20231.372 131 194 39 97 98 142 87 159 137 153 74 61
2023/2024820 33 87 52 77 69 159 109 19 20 24 93 78
2024/20252.664 118 134 204 231 88 87 283 151 200 253 295 620
2025/20268.642 468 386 767 884 778 1.118 1.121 976 684 494 478 488
2026/2027789 546 243 0 0 0 0 0 0 0 0 0 0
Totale 15.556